BAE Systems PLC (BAES.L)

BAES.L on London Stock Exchange

510.50GBp
10:50am EST
Change (% chg)

4.50p (+0.89%)
Prev Close
506.00p
Open
509.00p
Day's High
513.50p
Day's Low
504.50p
Volume
4,028,763
Avg. Vol
6,699,031
52-wk High
520.50p
52-wk Low
374.10p

BAES.L

Chart for BAES.L

About

BAE Systems plc (BAE Systems) is a global defense, aerospace and security company. BAE Systems delivers, a range of products and services for air, land and naval forces, as well as advanced electronics, security, information technology solutions and support services. The Company operates in five segments: Electronic Systems... (more)

Overall

Beta: 0.85
Market Cap(Mil.): £15,955.86
Shares Outstanding(Mil.): 3,153.33
Dividend: 8.20
Yield (%): 4.01

Financials

  BAES.L Industry Sector
P/E (TTM): 84.17 37.27 30.36
EPS (TTM): 0.06 -- --
ROI: 1.63 5.15 7.40
ROE: 5.38 12.84 11.08
Search Stocks

BAE Systems wins 112 mln stg Typhoon services contract extension

LONDON, Jan 20 - Defence company BAE Systems said it had won a 112 million pound ($170 million) contract from the British Ministry of Defence to continue to provide services to ensure the readiness of the country's Eurofighter Typhoon jets.

20 Jan 2015

BAE Systems wins $120 mln U.S. Navy Aegis support contract

LONDON, Jan 19 - British defence company BAE Systems said it had won a five-year contract worth an estimated $120 million to provide engineering and testing support for the U.S. Navy's Aegis weapon system onboard its ships.

19 Jan 2015

UPDATE 1-Two blue-chip companies drop UBS as corporate broking adviser-FT

Jan 12 - UBS Group AG, Switzerland's biggest bank, lost two more blue-chip corporate broking clients, the Financial Times reported, citing people familiar with the situation.

12 Jan 2015

European Factors to Watch-Shares seen steady, health sector in focus

LONDON, Jan 12 - European shares were seen opening steady on Monday, with healthcare stocks likely to come into focus after Shire Plc agreed to buy NPS Pharmaceuticals Inc for $5.2 billion. Futures on the euro zone's blue-chip Euro STOXX 50 index rose 0.5 percent, Germany's DAX futures advanced 0.4 percent while France's CAC futures rose 0.3 percent. On Sunday, Shire agreed to buy NPS Pharmaceuticals Inc for $5.2 billion in its biggest acquisition yet, as the Dublin-b

12 Jan 2015

European Factors to Watch-Shares seen steady, health sector in focus

LONDON, Jan 12 - European shares were seen opening steady on Monday, with healthcare stocks likely to come into focus after Shire Plc agreed to buy NPS Pharmaceuticals Inc for $5.2 billion. Financial spreadbetters expected Britain's FTSE 100 to open down by 10-14 points, or 0.2 percent lower. Germany's DAX was expected to open up by 11.5-31.5 points, or 0.1-0.3 percent higher, while France's CAC 40 was seen opening flat. Europe bourses in 2014: (http://link.reuters

12 Jan 2015

Two blue-chip companies drop UBS as their corporate broking adviser: FT

- UBS Group AG, Switzerland's biggest bank, has lost two more blue-chip corporate broking clients, the Financial Times reported, citing people familiar with the situation.

11 Jan 2015

Two blue-chip companies drop UBS as their corporate broking adviser -FT

Jan 11 - UBS Group AG, Switzerland's biggest bank, has lost two more blue-chip corporate broking clients, the Financial Times reported, citing people familiar with the situation.

11 Jan 2015

UPDATE 1-BAE wins U.S. Army contract worth up to $1.2 bln for new armored vehicle

(Adds Army comments on total replacement needs, paragraph 6)

23 Dec 2014

BAE wins U.S. Army contract worth up to $1.2 billion for new armored vehicle

WASHINGTON - BAE Systems has won a contract worth up to $1.2 billion to build a new type of armored vehicle for the U.S. Army, the company and Army officials said on Tuesday.

23 Dec 2014

BAE wins U.S. Army contract worth up to $1.2 bln for new armored vehicle

WASHINGTON, Dec 23 - BAE Systems has won a contract worth up to $1.2 billion to build a new type of armored vehicle for the U.S. Army, the company and Army officials said on Tuesday.

23 Dec 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks